Acute Exacerbation of Chronic Obstructive Pulmonary Disease Due to Carbapenem-Resistant Klebsiella pneumoniae-Induced Pneumonia: Clinical Features and Prognostic Factors
Pengwen Ouyang,Zhijie Zhou,Chanyuan Pan,Peijuan Tang,Sheng Long,Xiangjian Liao,Qiong Liu,Liangyi Xie
DOI: https://doi.org/10.2147/copd.s447905
2024-03-08
International Journal of COPD
Abstract:Pengwen Ouyang, 1 Zhijie Zhou, 2 Chanyuan Pan, 3 Peijuan Tang, 1 Sheng Long, 1 Xiangjian Liao, 1 Qiong Liu, 1 Liangyi Xie 1 1 Department of Clinical Laboratory, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, People's Republic of China; 2 Department of Respiratory Medicine, The Affiliated Zhuzhou Hospital of Xiangya School of Medicine, Central South University, Zhuzhou, People's Republic of China; 3 Department of Respiratory Medicine, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, People's Republic of China Correspondence: Liangyi Xie, Email Purpose: Carbapenem-resistant Klebsiella pneumoniae (CRKP) is closely related to respiratory tract infection. The aim of this study was to investigate the clinical features and prognostic factors of CRKP-induced pneumonia in acute exacerbation of chronic obstructive pulmonary disease (AECOPD) patients. Methods: A single-centre, retrospective case-control study on COPD patients hospitalized for acute exacerbation and CRKP-induced pneumonia was conducted from January 1, 2016, to December 31, 2022. The mortality rate of acute exacerbation due to CRKP-induced pneumonia was investigated. The patients were divided into the CRKP-induced pneumonic acute exacerbation (CRKPpAE) group and the non-CRKP-induced pneumonic acute exacerbation (non-CRKPpAE) group, and the clinical characteristics and prognostic factors were compared using univariate analysis and multivariate analysis. Results: A total of 65 AECOPD patients were included, composed of 26 patients with CRKPpAE and 39 patients with non-CRKPpAE. The mortality rate of CRKPpAE was 57.69%, while non-CRKPpAE was 7.69%. Compared with non-CRKPpAE, a history of acute exacerbation in the last year (OR=8.860, 95% CI: 1.360– 57.722, p =0.023), ICU admission (OR=11.736, 95% CI: 2.112– 65.207, p =0.005), higher NLR levels (OR=1.187, 95% CI: 1.037– 1.359, p =0.013) and higher D-dimer levels (OR=1.385, 95% CI: 1.006– 1.905, p =0.046) were independently related with CRKPpAE. CRKP isolates were all MDR strains (26/26, 100%), and MDR strains were also observed in non-CRKP isolates (5/39, 12.82%). Conclusion: Compared with non-CRKPpAE, CRKPpAE affects the COPD patient's condition more seriously and significantly increases the risk of death. Keywords: chronic obstructive pulmonary disease, acute exacerbation, carbapenem-resistant K. pneumoniae , pneumonia Carbapenem-resistant Klebsiella pneumoniae (CRKP) is a notorious pathogen worldwide that can cause pneumonia, bloodstream infections, urinary tract infections or wound infections, which are often difficult or even impossible to treat. 1 Carbapenems often serve as the final effective line of defense against infections caused by multidrug-resistant K. pneumoniae , and multiple mechanisms contribute to the development of drug-resistant strains. 2 In China, the prevalence of CRKP has shown an alarming upward trend and has become a serious threat to public health due to high drug resistance, hypervirulence, and high fatality rates. 3,4 Worryingly, this trend has been observed globally. 5 Chronic obstructive pulmonary disease (COPD) is a complex and heterogeneous lung disease characterized by persistent, progressive airflow obstruction. Acute exacerbation of chronic obstructive pulmonary disease (AECOPD) is a state in which respiratory symptoms of COPD are rapidly exacerbated, with bacterial infection being one of the main causes. 6 When AECOPD is complicated by bronchial infection or pneumonia, in-hospital mortality significantly increases, particularly in elderly patients. 7 In 2015, 99.9 million Chinese adults suffered from COPD, making it the third most common chronic disease after hypertension and diabetes in China. 8 Acute exacerbation increases the frequency of hospitalization in COPD patients, seriously affects the quality of life, and commonly accompanies a heavy economic burden. 9 Previous studies have reported the association of Haemophilus influenzae or Streptococcus pneumoniae with AECOPD. 10 However, pathogen types in COPD patients' sputum appear to vary by population and geographic location. In China, some studies have identified K. pneumoniae as one of the most common pathogens ( Pseudomonas aeruginosa, Acinetobacter baumannii and Staphylococcus aureus in addition) in the sputum of AECOPD patients. 11,12 In recent years, there has been a rapid escalation in the drug res -Abstract Truncated-
respiratory system